Oligomeric α-synuclein level in peripheral red blood cells of patients with acute ischemic stroke
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective Alpha-synuclein has been suggested to be related with the etiology of Parkinson’s disease (PD) and other neurodegenerative disorders. Hypoxia injury has been indicated to be associated with α-synuclein accumulation. But no report has linked the α-synuclein with the pathogenesis of stroke. This study aimed to investigate the level of oligomeric forms of α-synuclein in the patients with acute ischemic stroke (AIS). Methods Fifty-five patients with PD, 55 patients with AIS and 55 healthy individuals were recruited in this study. Their blood samples were characterized by a sandwich ELISA with purified recombinant α-synuclein as a test standard for further detection. Results The level of oligomeric α-synuclein in the red blood cells was (0.41±0.14), (0.82±0.55), and (1.01±0.56)mmol/L respectively for the healthy control, PD and AIS groups. The AIS group had significantly higher α-synuclein level compared with either the healthy controls (P<0.001, 95%CI=0.426?0.773) or the PD patients (P=0.027, 95%CI 0.022?0.369). Conclusion The level of oligomeric α-synuclein in red blood cells is significantly higher in patients with AIS, which may be involved in the pathophysiological changes in AIS, while its clinical significance requires further exploration.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: September 21,2015
  • Published:
Article QR Code